Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 14/20 | 0.74 |
| ▸ | CTSL | P07711 | 13/20 | 0.74 |
| ▸ | CTSB | P07858 | 13/20 | 0.74 |
| ▸ | CTSK | P43235 | 11/20 | 0.74 |
| ▸ | NPPA | P01160 | 2/20 | 0.38 |
| ▸ | MME | P08473 | 2/20 | 0.38 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.38 |
| ▸ | TACR2 | P21452 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7530898 | 0.94 | CTSS (0.65) | CTSSCTSLCTSBCTSK | |
| SCHEMBL7530008 | 0.91 | CTSK (0.63) | CTSSCTSLCTSBCTSKNPPA | |
| SCHEMBL7530137 | 0.91 | CTSS (0.62) | CTSSCTSLCTSBCTSKNPPA | |
| SCHEMBL7530187 | 0.89 | CTSS (0.57) | CTSSCTSLCTSBCTSKNPPA | |
| SCHEMBL7532290 | 0.88 | CTSS (0.58) | CTSSCTSLCTSBCTSKNPPA | |
| SCHEMBL7533061 | 0.87 | CTSS (0.56) | CTSSCTSLCTSBCTSKNPPA | |
| SCHEMBL7526705 | 0.87 | CTSS (0.55) | CTSSCTSLCTSBCTSKNPPA | |
| SCHEMBL7531164 | 0.86 | CTSS (0.54) | CTSSCTSLCTSBCTSKNPPA | |
| SCHEMBL7533810 | 0.86 | CTSL (0.54) | CTSSCTSLCTSBCTSKNPPA | |
| SCHEMBL7530107 | 0.85 | CTSK (0.58) | CTSSCTSLCTSBCTSKNPPA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002023784-A2 | CYSTEINE PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-03-21 | — | — | WO | claimed |
| WO-2002023784-A2 | CYSTEINE PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-03-21 | — | — | WO | disclosed |